Cost-effectiveness analysis of escitalopram in the treatment of Major Depressive Disorder in Germany

Kulp W, Hemels M, Greiner W, von der Schulenburg J (2005)
Value in Health 8(6): A210.

Download
No fulltext has been uploaded. References only!
Conference Abstract | Published | English

No fulltext has been uploaded

Author
; ; ;
Publishing Year
ISSN
PUB-ID

Cite this

Kulp W, Hemels M, Greiner W, von der Schulenburg J. Cost-effectiveness analysis of escitalopram in the treatment of Major Depressive Disorder in Germany. Value in Health. 2005;8(6):A210.
Kulp, W., Hemels, M., Greiner, W., & von der Schulenburg, J. (2005). Cost-effectiveness analysis of escitalopram in the treatment of Major Depressive Disorder in Germany. Value in Health, 8(6), A210. doi:10.1016/S1098-3015(10)67792-3
Kulp, W., Hemels, M., Greiner, W., and von der Schulenburg, J. (2005). Cost-effectiveness analysis of escitalopram in the treatment of Major Depressive Disorder in Germany. Value in Health 8, A210.
Kulp, W., et al., 2005. Cost-effectiveness analysis of escitalopram in the treatment of Major Depressive Disorder in Germany. Value in Health, 8(6), p A210.
W. Kulp, et al., “Cost-effectiveness analysis of escitalopram in the treatment of Major Depressive Disorder in Germany”, Value in Health, vol. 8, 2005, pp. A210.
Kulp, W., Hemels, M., Greiner, W., von der Schulenburg, J.: Cost-effectiveness analysis of escitalopram in the treatment of Major Depressive Disorder in Germany. Value in Health. 8, A210 (2005).
Kulp, W., Hemels, M., Greiner, Wolfgang, and von der Schulenburg, J. “Cost-effectiveness analysis of escitalopram in the treatment of Major Depressive Disorder in Germany”. Value in Health 8.6 (2005): A210.
This data publication is cited in the following publications:
This publication cites the following data publications:

Export

0 Marked Publications

Open Data PUB

Web of Science

View record in Web of Science®

Search this title in

Google Scholar